Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound reserpine and triamterene tablet versus placebo in stage 1 hypertension
ChiCTR1800015493Phase 4Recruiting
- Sponsor
- Shanghai Institute of Hypertension
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of reserpine and triamterene in hypertension (HTN) (2 arms), sponsored by Shanghai Institute of Hypertension. Primary endpoint: Plasma monoamine neurotransmitter levels. Started Apr 2018; status: recruiting.
02
Drugs
reserpinetriamterene
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR1800015493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015493.